LC
PACB icon

Lindbrook Capital’s Pacific Biosciences PACB Stock Holding History

Lindbrook Capital’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$2.54K Sell
2,150
-168
-7% -$258 ﹤0.01% 2214
2024
Q4 		$4.24K Buy
2,318
+483
+26% +$943 ﹤0.01% 2057
2024
Q3 		$3.12K Sell
1,835
-797
-30% -$1.31K ﹤0.01% 2203
2024
Q2 		$3.61K Buy
2,632
+2,332
+777% +$4.71K ﹤0.01% 2137
2024
Q1 		$1.13K Hold
300
– – ﹤0.01% 2392
2023
Q4 		$2.94K Hold
300
– – ﹤0.01% 2125
2023
Q3 		$2.5K Sell
300
-34
-10% -$389 ﹤0.01% 2044
2023
Q2 		$4.44K Buy
334
+34
+11% +$413 ﹤0.01% 1863
2023
Q1 		$3.47K Sell
300
-132
-31% -$1.31K ﹤0.01% 2015
2022
Q4 		$3.53K Buy
432
+86
+25% +$741 ﹤0.01% 1981
2022
Q3 		$2K Buy
346
+300
+652% +$1.72K ﹤0.01% 2111
2022
Q2 		$0 Sell
46
-391
-89% -$2.38K ﹤0.01% 2688
2022
Q1 		$4K Buy
437
+201
+85% +$2.31K ﹤0.01% 1729
2021
Q4 		$5K Sell
236
-82
-26% -$1.98K ﹤0.01% 1518
2021
Q3 		$8K Sell
318
-16
-5% -$474 ﹤0.01% 1091
2021
Q2 		$12K Hold
334
– – ﹤0.01% 983
2021
Q1 		$11K Hold
334
– – ﹤0.01% 988
2020
Q4 		$9K Hold
334
– – ﹤0.01% 962
2020
Q3 		$3K Buy
334
+331
+11,033% +$1.91K ﹤0.01% 1293
2020
Q2 		$0 Buy
+3
New +$10 ﹤0.01% 1844
2020
Q1 		– Sell
-298
Closed -$2K – 1813
2019
Q4 		$2K Buy
+298
New +$1.51K ﹤0.01% 1309

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's PACB Position: Q1 2025 in Review

Lindbrook Capital reduced its Pacific Biosciences (PACB) stake by 7.2% in Q1 2025, selling an estimated $258 and leaving 2,150 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #2214.

Lindbrook Capital first reported a position in PACB in Q4 2019 and has held it in 21 quarters since. The position peaked at $12K in Q2 2021. 225 funds tracked by Wall St. Rank hold PACB as of Q1 2025.

  • Lindbrook Capital held 2,150 shares of Pacific Biosciences worth $2.54K as of Q1 2025.
  • Lindbrook Capital sold 168 Pacific Biosciences shares in Q1 2025, an estimated $258.
  • Pacific Biosciences made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2214 holding.
  • Lindbrook Capital first reported a position in Pacific Biosciences in Q4 2019 and has held it in 21 quarters since.
  • Lindbrook Capital's Pacific Biosciences position peaked at $12K in Q2 2021.
  • 225 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.